Literature DB >> 6297863

Vitamin D deficiency, osteomalacia, and primary biliary cirrhosis. Response to orally administered vitamin D3.

M Davies, E B Mawer, H J Klass, G A Lumb, J L Berry, T W Warnes.   

Abstract

Five patients with primary biliary cirrhosis and vitamin D deficiency (serum 25-hydroxyvitamin D less than 6 ng/ml) are presented. All patients had low serum 24,25-dihydroxyvitamin D3 concentrations. Three patients had histological osteomalacia, negative calcium balance, and subnormal serum 1,25-dihydroxyvitamin D3. Malabsorption of a standard dose of [3H]vitamin D3 was found in three of four patients with steatorrhea, enabling the effective dose of vitamin D3 given to be calculated. Oral vitamin D3 400-4000 IU/day (effectively 400-1860 IU/day) resulted in a return to normal of the serum vitamin D metabolites, correction of the impaired intestinal calcium absorption and healing of the osteomalacia. Increases in serum calcium, phosphate, and the renal tubular reabsorption of phosphate occurred with a concomitant decrease in serum parathyroid hormone. It is suggested that osteomalacia in primary biliary cirrhosis is the end result of vitamin D deficiency; the hepatic and renal hydroxylations of vitamin D are normal and target tissues are responsive to endogenously produced metabolites of vitamin D.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6297863     DOI: 10.1007/bf01315144

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Formation of vitamin D metabolites from 3H- and 14C-radiolabelled vitamin D-3 in chronic liver diseases.

Authors:  R G Long; R K Skinner; M R Wills; S Sherlock
Journal:  Clin Chim Acta       Date:  1978-05-02       Impact factor: 3.786

2.  Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy.

Authors:  A K Kehayoglou; C D Holdsworth; J E Agnew; M J Whelton; S Sherlock
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

3.  Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease.

Authors:  R G Long; E Meinhard; R K Skinner; Z Varghese; M R Wills; S Sherlock
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

4.  Treatment of osteomalacia associated with primary biliary cirrhosis with oral 1-alpha-hydroxy vitamin D3.

Authors:  J E Compston; J P Crowe; L W Horton
Journal:  Br Med J       Date:  1979-08-04

5.  25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man.

Authors:  S B Arnaud; R S Goldsmith; P W Lambert; V L Go
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

6.  Measurement of 1,25-dihydroxycholecalciferol in man by radioimmunoassay.

Authors:  T L Clemens; G N Hendy; S E Papapoulos; L J Fraher; A D Care; J L O'Riordan
Journal:  Clin Endocrinol (Oxf)       Date:  1979       Impact factor: 3.478

7.  Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis.

Authors:  M M Kaplan; M J Goldberg; D S Matloff; R M Neer; D B Goodman
Journal:  Gastroenterology       Date:  1981-10       Impact factor: 22.682

8.  Comparative absorption of vitamin D3 and 25-hydroxyvitamin D3 in intestinal disease.

Authors:  M Davies; E B Mawer; E L Krawitt
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

9.  Bone disease in primary biliary cirrhosis: reversal of osteomalacia with oral 25-hydroxyvitamin D.

Authors:  J S Reed; S C Meredith; B A Nemchausky; I H Rosenberg; J L Boyer
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

10.  Absorption, hydroxylation, and excretion of vitamin D3 in primary biliary cirrhosis.

Authors:  E L Krawitt; M J Grundman; E B Mawer
Journal:  Lancet       Date:  1977-12-17       Impact factor: 79.321

View more
  8 in total

Review 1.  Bone disease after liver transplantation.

Authors:  M S Losowsky; S H Hussaini
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

Review 2.  Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease.

Authors:  J E Compston
Journal:  Gut       Date:  1986-09       Impact factor: 23.059

Review 3.  Vitamin D Metabolism and Guidelines for Vitamin D Supplementation.

Authors:  Indra Ramasamy
Journal:  Clin Biochem Rev       Date:  2020-12

Review 4.  25 Hydroxyvitamin D and vitamin E absorption in healthy children and children with chronic intrahepatic cholestasis.

Authors:  S Issa; H W Rotthauwe; W Burmeister
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

5.  Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.

Authors:  S A Brown; D A Ontjes; G E Lester; R K Lark; M B Hensler; A D Blackwood; M J Caminiti; D C Backlund; R M Aris
Journal:  Osteoporos Int       Date:  2003-05-28       Impact factor: 4.507

6.  Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.

Authors:  D D Bikle; E Gee; B Halloran; J G Haddad
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

7.  Hepatic osteodystrophy in rats results mainly from portasystemic shunting.

Authors:  S W van der Merwe; J B van den Bogaerde; C Goosen; F F Maree; R J Milner; C M Schnitzler; A Biscardi; J M Mesquita; G Engelbrecht; D Kahn; J Fevery
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

8.  A randomized two way cross over study for comparison of absorption of vitamin D3 buccal spray and soft gelatin capsule formulation in healthy subjects and in patients with intestinal malabsorption.

Authors:  M C Satia; A G Mukim; K D Tibrewala; M S Bhavsar
Journal:  Nutr J       Date:  2015-10-29       Impact factor: 3.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.